Medivir AB (FRA:MVR0)
€ 0.211 -0.017 (-7.46%) Market Cap: 27.91 Mil Enterprise Value: 14.54 Mil PE Ratio: 0 PB Ratio: 1.77 GF Score: 44/100

Q4 2019 Medivir AB Earnings Call Transcript

Feb 13, 2020 / 01:00PM GMT
Release Date Price: €0.96747 (+1.63%)
Operator

Ladies and gentlemen, welcome to Medivir AB Q4 Report 2019. (Operator Instructions) Today, I am pleased to present CEO, Uli Hacksell; and CFO, Magnus Christensen. Speakers, please begin.

Uli Hacksell;publ;CEO
Medivir AB;President & Director

()- -

Good afternoon, and welcome to our 2019 Q4 call. With me today are Magnus Christensen, our CFO; Linda Basse, our Chief Medical Officer; and Christina Herder, our COO. So let me take you to the first 2 slides very quickly. We have one slide with the forward-looking statements that you can take a look at later on. And let's move to Slide #3, which is the financial summary slide that will be presented by Magnus. Please, Magnus.

Magnus Christensen;publ;CFO
Medivir AB

()-

Thank you, Uli. And yes, please see Slide #3, where you can see the financial summary for quarter 4 and the financial year 2019. The turnover for quarter 4 amounts to around SEK 1 million, which is lower than last year, and it relates

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot